No Detail Found!

Comparison of efficacy and safety of zinc gluconate versus placebo for treatment of primary dysmenorrhea

Author(s)
Faiza Safdar Department of Obstetrics & Gynaecology, Wah Medical College, Wah Cantt. Pakistan
Shabana Kalsoom Department of Obstetrics & Gynaecology, Wah Medical College, Wah Cantt, Pakistan
Noreen Majeed Department of Obstetrics & Gynaecology, Wah Medical College, Wah Cantt, Pakistan
Khairun Nisa Department, Obstetrics & Gynaecology, Wah Medical College, Wah Cantt, Pakistan
Mamoona Riaz Department of Obstetrics & Gynaecology, Wah Medical College, Wah Cantt, Pakistan
Shamsa Tariq Department, Obstetrics & Gynaecology, Wah Medical College, Wah Cantt, Pakistan
Abstract
Introduction: Dysmenorrhea is a common gynecological complaint in women of reproductive age. Primary dysmenorrhea is defined as painful menstruation in the absence of any pelvic pathology and occurs in response to increased prostaglandin release from the ischemic endometrium. Conventional treatments include NSAIDs and oral contraceptive pills. Zinc is an essential micronutrient with anti-inflammatory properties. We conducted this study to evaluate the efficacy and safety of zinc supplementation in the treatment of primary dysmenorrhea in our target population as it presents as a very common gynaecological issue in young adolescent females. Materials and Methods: 100 participants with primary dysmenorrhea were enrolled in the study from the outpatient department via non-probability consecutive sampling. They were randomized into two groups. The intervention group (Group A) received zinc gluconate 50mg once daily and the control group (Group B) received a placebo drug once daily, for 5 days before and 2 days after the onset of menstruation. After three and six months of treatment severity of primary dysmenorrhea was assessed and compared in both groups using a visual analogue scale for pain, along with the side effect profile. Results: The treatment with Zinc gluconate reduced the mean pain score in females with primary dysmenorrhea after 3 months with a further reduction after 6 months of treatment (P<0.001) as compared to placebo. Very few (4% after 3 months & 6% after 6 months) participants experienced the side effects of Zinc supplementation. Conclusion: Zinc gluconate 50mg daily for 5 days before and 2 days after the onset of menstruation can effectively treat primary dysmenorrhea. The drug has very few side effects at this dose and duration of use.
Publication Details
Page(s) 363-367
Published Journal: Journal of Rawalpindi Medical College, Volume: 26, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
Primary dysmenorrhea, Visual Analogue Scale., zinc gluconate, Pain severity
0

Citations

0

Downloads

56

Views